OLD REPUBLIC INTERNATIONAL CORP
In the published model solve dated 2026-Q2, anchored at $43.52, OLD REPUBLIC INTERNATIONAL CORP (ORI) is priced for 12.4% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
- At $38.70 the price implies Old Republic sustaining a return on equity near 11.8% for about 1.6x book, against the roughly 15.8% it has been earning recently. That is a price asking for less than the business has delivered, which is unusual for an insurer. - The Q1 2026 print was softer underneath the headline. Net income rose to $330 million on investment gains, but net operating income fell to $170.5 million from $201.7 million and the consolidated combined ratio worsened to 96.6% from 93.7%
Is ORI overvalued? See what's priced in →
637 institutional managers reported holding ORI in 13F filings for the quarter ended 2026-03-31. Together they hold about 74% of the company; the top 10 hold 45%. 65 opened new positions that quarter. Held by BlackRock, Vanguard Group, BNY Mellon, among others. On the short side, 8.7M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (6.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ORI has cut its share count 19% over the past five years, spending $2.05B on repurchases. It pays a dividend, and has paid one every year in our records (16 and counting), raised 2 years straight; the current rate is $3.66 a share annually. Cash returned over the past three years: $1.88B in dividends and $1.42B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ORI over the trailing three years: 2023: 3 buys totaling $107k; 2024: 7 buys totaling $266k; 2025: 3 buys totaling $99k; 2026: 2 buys totaling $49k. 20 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ORI's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-08 | +1.4% | -4.3% |
| 2023-11-04 | +0.5% | +5.9% |
| 2024-02-29 | -7.8% | +5.9% |
| 2024-05-04 | -0.5% | -2.5% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ORI's latest 8-K filings: 2026-07-23 (items 2.02, 9.01); 2026-07-01 (items 7.01, 9.01); 2026-05-27 (items 5.07, 9.01); 2026-05-18 (items 1.01, 2.03, 9.01); 2026-04-23 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.